Retraction Note: Overexpressing p130/E2F4 in mesenchymal stem cells facilitates the repair of injured alveolar epithelial cells in LPS-induced ARDS mice (Stem Cell Research & Therapy, (2019), 10, 1, (74), 10.1186/s13287-019-1169-1);Overexpressing p130/E2F4 in mesenchymal stem cells facilitates the repair of injured alveolar epithelial cells in LPS-induced ARDS mice

Stem Cell Research and Therapy

Volumn 10, Issue 1, 2019, Pages

  Zhang, Xiwen ^a   Chen, Jianxiao ^a   Xue, Ming ^a   Tang, Yuying ^a   Xu, Jingyuan ^a   Liu, Ling ^a   Huang, Yingzi ^a   Yang, Yi ^a   Qiu, Haibo ^a   Guo, Fengmei ^a  

^a AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Acute respiratory distress syndrome; Differentiation into type II alveolar epithelial cells; E2F4; Mesenchymal stem cells; P130

Indexed keywords

COLLAGEN; OCCLUDIN; PROTEIN P130; SURFACTANT PROTEIN A; SURFACTANT PROTEIN C; TRANSCRIPTION FACTOR E2F4; E2F4 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; RBL2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; CONTROLLED STUDY; LIPOPOLYSACCHARIDE-INDUCED ACUTE LUNG INJURY; LUNG ALVEOLUS CELL TYPE 2; LUNG EDEMA; LUNG FIBROSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS SYNDROME; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGRAFT; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION; GENETICS; LUNG ALVEOLUS EPITHELIUM CELL; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY;

ALLOGRAFTS; ALVEOLAR EPITHELIAL CELLS; ANIMALS; CELL DIFFERENTIATION; E2F4 TRANSCRIPTION FACTOR; GENE EXPRESSION; LIPOPOLYSACCHARIDES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; RESPIRATORY DISTRESS SYNDROME, ADULT; RETINOBLASTOMA-LIKE PROTEIN P130;

EID: 85062583370     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/s13287-022-02867-3     Document Type: Erratum

References (26)

1. Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med. 2015;3:24-32.
2. Villar J, Blanco J, Kacmarek RM. Current incidence and outcome of the acute respiratory distress syndrome. Curr Opin Crit Care. 2016;22:1-6.
3. Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med. 2017;377:562-72.
4. Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126-36.
5. Matthay MA, McAuley DF, Ware LB. Clinical trials in acute respiratory distress syndrome: Challenges and opportunities. Lancet Respir Med. 2017;5:524-34.
6. Laffey JG, Matthay MA. Fifty years of research in ARDS. Cell-based therapy for acute respiratory distress syndrome. Biology and potential therapeutic value. Am J Respir Crit Care Med. 2017;196:266-73.
7. Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): A randomised phase 2a safety trial. Lancet Respir Med. 2019;7(2):154-162.
8. Cai SX, Liu AR, Chen S, et al. Activation of Wnt/beta-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Stem Cell Res Ther. 2015;6:65.
9. Cai SX, Liu AR, Chen S, et al. The orphan receptor tyrosine kinase ROR2 facilitates MSCs to repair lung injury in ARDS animal model. Cell Transplant. 2016;25:1561-74.
10. Zhang X, Chen J, Liu A, et al. Stable overexpression of p130/E2F4 affects the multipotential abilities of bone-marrow-derived mesenchymal stem cells. J Cell Physiol. 2018;233:9739-49.
11. Mrozek JD, Smith KM, Bing DR, et al. Exogenous surfactant and partial liquid ventilation: Physiologic and pathologic effects. Am J Respir Crit Care Med. 1997;156:1058-65.
12. He H, Liu L, Chen Q, et al. Mesenchymal stem cells overexpressing angiotensin-converting enzyme 2 rescue lipopolysaccharide-induced lung injury. Cell Transplant. 2015;24:1699-715.
13. Gao X, Qian J, Zheng S, et al. Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. ACS Nano. 2014;8:3678-89.
14. Sun Z, Wang Y, Gong X, et al. Secretion of rat tracheal epithelial cells induces mesenchymal stem cells to differentiate into epithelial cells. Cell Biol Int. 2012;36:169-75.
15. Hu S, Li J, Xu X, et al. The hepatocyte growth factor-expressing character is required for mesenchymal stem cells to protect the lung injured by lipopolysaccharide in vivo. Stem Cell Res Ther. 2016;7:66.
16. Flodby P, Kim YH, Beard LL, et al. Knockout mice reveal a major role for alveolar epithelial type I cells in alveolar fluid clearance. Am J Respir Cell Mol Biol. 2016;55:395-406.
17. Trac PT, Thai TL, Linck V, et al. Alveolar nonselective channels are ASIC1a/alpha-ENaC channels and contribute to AFC. Am J Physiol Lung Cell Mol Physiol. 2017;312:L797-811.
18. Hashimoto N, Kawabe T, Imaizumi K, et al. CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. Am J Respir Cell Mol Biol. 2004;30:808-15.
19. Huppert LA, Liu KD, Matthay MA. Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS. Transfusion. 2019;59(S1):869-875.
20. Xu XP, Huang LL, Hu SL, et al. Genetic modification of mesenchymal stem cells overexpressing angiotensin II type 2 receptor increases cell migration to injured lung in LPS-induced acute lung injury mice. Stem Cells Transl Med. 2018;7:721-30.
21. Fiorentino FP, Symonds CE, Macaluso M, et al. Senescence and p130/Rbl2: A new beginning to the end. Cell Res. 2009;19:1044-51.
22. Li H, Collado M, Villasante A, et al. p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation. Cell Stem Cell. 2012;11:845-52.
23. Mei SH, McCarter SD, Deng Y, et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 2007;4:e269.
24. Kotton DN, Ma BY, Cardoso WV, et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development. 2001;128:5181-8.
25. Berger MJ, Adams SD, Tigges BM, et al. Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy. 2006;8:480-7.
26. Epperly MW, Guo H, Gretton JE, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003;29:213-24.